CDT CDT Equity Inc. logo

CDT CDT Equity Inc.

Healthcare
$1.05-13.93%ClosedMarket Cap: $5.1M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

0.00

PEG

0.00

P/B

0.03

P/S

0.01

EV/EBITDA

13.52

DCF Value

$1,690,601.09

FCF Yield

-116.7%

Div Yield

0.0%

Margins & Returns

Gross Margin

36.9%

Operating Margin

6.4%

Net Margin

2.4%

ROE

2.6%

ROA

0.5%

ROIC

0.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$696.4M$51.0M$
Q4 null$0.00$-21.3M$
FY null$2.72B$237.5M$
Q3 null$0.00$-7.1M$

Trading Activity

Insider Trades

View All
Regan Andrewdirector, officer: Chief Executive Officer
SellThu May 14
Regan Andrewdirector, officer: Chief Executive Officer
SellThu May 14
Regan Andrewdirector, officer: Chief Executive Officer
SellThu May 14
Olsen Ulrik Kdirector
SellThu Apr 30
Taylor Mark Andrew10 percent owner
SellMon Mar 30

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

1.57

CDT Equity, Inc. engages in facilitating the development and commercialization of clinical assets. The company was founded by David Joszef Tapolczay and Freda C. Lewis-Hall in October 2021 is headquartered in Naples, FL.

Peers